Comments Extended on Device Labeling Workshop
03/25/2013
Federal Register Notice: FDA is extending the comment period for a 1/7 Federal Register notice requesting comments on the public w...
Benadryl, Flexeril Not Withdrawn for S&E
03/25/2013
Comments Sought on Regs for Medical Gases
03/22/2013
Federal Register Notice: FDA is inviting comments from the public on whether any potential changes to the federal drug regulations...
Change of Animal Drug Sponsor to Bayer HealthCare
03/22/2013
Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor for 21 approved NADAs and ...
Panel To Discuss GSK NDA for Breo Ellipta
03/21/2013
Risk Communications Panel to Meet
03/21/2013
Federal Register Notice: FDA’s Risk Communications Advisory Committee will meet 4/29, from 8 a.m. to 5 p.m. and 4/30, from 8...
FDA Publishes List of Approved PMAs
03/21/2013
Comments Sought on Infusion Pump 510(k)s
03/18/2013
FDA Withdraws Impax Labs’ Budeprion XL
03/18/2013
Comments Sought on Smokeless Tobacco Labeling
03/18/2013
Federal Register Notice: FDA is seeking public comment on a proposed collection of information on submitting rotational plans for ...
